Areolar-Cutaneous "Junction" Injections to Augment Sentinel Node Count Activity

Clinical Nuclear Medicine

Volumn 28, Issue 2, 2003, Pages 97-107

  Krynyckyi, Borys R ^a,d   Kim, Chun K ^a   Mosci, Karina ^a   Fedorciw, Boris J ^b,c   Zhang, Zhuang Yu ^a   Lipszyc, Helena ^a   Machac, Josef ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SAINT PETER S UNIVERSITY HOSPITAL   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Areola; Breast Cancer; LymphoBoost; Lymphoscintigraphy; Sentinel Node; Specific Activity

Indexed keywords

EMLA; TECHNETIUM SULFUR COLLOID TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AMBULATORY SURGERY; AREOLAR CUTANEOUS JUNCTION; ARTICLE; CALCULATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; EXCISION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPHOBOOST TECHNIQUE; LYMPHOCYTE ACTIVATION; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE; STANDARD; STATISTICAL SIGNIFICANCE; BREAST; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; INTRADERMAL DRUG ADMINISTRATION; INTRALESIONAL DRUG ADMINISTRATION; LYMPH NODE; PATHOLOGY; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRALESIONAL; LYMPH NODES; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 85047694471     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RLU.0000048942.43732.1F     Document Type: Article

References (48)

1. Mariani G, Moresco L, Viale G, et al: Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 42:1198, 2001.
2. Krynyckyi BR, Firestone M, Eskandar Y, et al: Dual method injection technique for breast lymphoscintigraphy to maximize visualization of sentinel nodes [Abstract]. J Nucl Med 41:281P, 2000.
3. Shimazu K, Tamaki Y, Taguchi T, et al: Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery 131: 277, 2002.
4. Kimberg VS, Rubio IT, Henry R, et al: Subareolar versus perilesional injection for location of the sentinel lymph node. Ann Surg 229:860, 1999.
5. Mertz L, Mathelin C, Marin C, et al: Subareolar injection of 99m-Tc sulfur colloid for sentinel nodes identification in multifocal invasive breast cancer. Bull Cancer 86:939, 1999.
6. Roumen RMH, Geuskens LM, Valkenburg JGH: In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol 25:347, 1999.
7. Smith LF, Cross MJ, Klimberg VS: Subareolar injection is a better technique for sentinel lymph node biopsy. Am J Surg 180:434, 2000.
8. Kern KA, Rosenberg RJ: Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid. J Am Coll Surg 191:479, 2000.
9. Alazraki N, Styblo T, Grant S, et al: Optimum injection methods (peritumoral [PT], subdermal [SD] and periareolar [PA] to image sentinel lymph nodes (SLNS) in breast cancer [Abstract]. J Nucl Med 42:116p, 2001.
10. Gambir S, Azad M, Barlow R, et al: Tumor quadrant and depth independent subareolar injection of 99mTc-albumin colloid (AC) and blue dye (BD) in detection of sentinel lymph nodes/s (SLN) in carcinoma breast [Abstract]. J Nucl Med 42:116p, 2001.
11. Winzer KJ, Geworski L, Zander A, et al: Prospective intraindividual comparative study of peritumoral and subareolar application of 99mTc nanocolloid in sentinel node (SN) detection in breast cancer [Abstract]. J Nucl Med 42:117, 2001.
12. Kern KA: Breast lymphatic mapping using subareolar injections of blue dye and radiocolloid: illustrated technique. J Am Coll Surg 192:545, 2001.
13. Donahue EJ: Sentinel node imaging and biopsy in breast cancer patients. Am J Surg 182:426, 2001.
14. Tuttle TM, Colbert M, Christensen R, et al: Subareolar injection of 99mTc facilitates sentinel lymph node identification. Ann Surg Oncol 9:77, 2002.
15. Krynyckyi BR, Zhang ZY, Kim CK, et al: Effects of high specific activity sulfur colloid preparations on sentinel node count rates [Abstract]. J Nucl Med 42:295P, 2001.
16. Krynyckyi BR, Miner M, Ragonese JM, et al: Technical aspects of performing lymphoscintigraphy: optimization of methods used to obtain images. Clin Nucl Med 25:978, 2000.
17. Zar JH: Biostatistical Analysis, 2nd ed. Two-Sample Hypotheses. Englewood Cliffs, New Jersey: Prentice-Hall, 1984, pp 122-49.
18. Bembenek A, Reuhl T, Markwardt J, et al: Sentinel lymph node dissection in breast cancer. Swiss Surg 5:217, 1999.
19. Feldman SM, Krag DN, McNally RK, et al: Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 188:248, 1999.
20. Wong SL, Edwards MJ, Chao C, et al: The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 9:272, 2002.
21. Haigh PI, Hansen NM, Giuliano AE, et al: Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med 41:1682, 2000.
22. Czerniecki BJ, Scheff AM, Callans LS, et al: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85:1098, 1999.
23. Tanis PJ, Nieweg OE, Oolmos RAV, et al: Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 192:399, 2001.
24. Krag D, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 339:941, 1998.
25. Gommans GMM, Boer RO, van Dongen A, et al: Optimization of 99m Tc-Nanocoll sentinel node localization in carcinoma of the breast [Letter]. Eur J Nucl Med 27:744, 2000.
26. Gommans GMM, Boer RO, van Dongen A, et al: Optimization of 99m Tc-Nanocoll sentinel node localization in carcinoma of the breast [Abstract]. Eur J Nucl Med 27:1006, 2000.
27. Krynyckyi BR, Zhang ZY, Kim CK, et al: Effects of high specific activity sulfur colloid preparations on sentinel node count rates. Clin Nucl Med 27:92, 2002.
28. Gommans GMM, van Dongen A, van der Schors TG, et al: Further optimization of 99mTc Nanocoll sentinel node localization in carcinoma of the breast by improved labeling. Eur J Nucl Med 28:1450, 2001.
29. Valdes ORA, Tanis PJ, Hoefnagel CA, et al: Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 22:579, 2001.
30. McMasters KM, Wong SL, Martin RC 2nd, et al: Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi institutional study. Ann Surg 233:676, 2001.
31. Rettenbacher L, Kassmann H, Galvan G, et al: Lymphoscintigraphy in breast cancer patients-comparison of peritumoural and intradermal injection. Nuklearmedizin 39:152, 2000.
32. Linehan DC, Hill AD, Akhurst T, et al: Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 6:450, 1999.
33. Cody HS 3rd, Borgen PI: State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol 8:85, 1999.
34. Kern KA, Rosenberg RJ: Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid. J Am Coll Surg 191:479, 2000.
35. Mokbel K, Mostafa A: The role of blue dye in identifying the sentinel node in patients with invasive breast cancer. Curr Med Res Opin 17:93, 2001.
36. Baichev G, Sergieva S, Gorchev G: Sentinel lymph nodes identification in early breast cancer-peritumoral or subareolar injection of lymphotropic blue dye? Radiol Oncol 35:43, 2001.
37. Alazraki NP, Grant S, Styblo T, et al: Perilesional (PT) vs subdermal (SD) injection methods for sentinel lymph node (SLN) imaging and intraoperative localization using 2 filtration sizes [Abstract]. J Nucl Med 41:71P, 2000.
38. Van der Ent FWC, Kengen RAM, Van der Pol HAG, et al: Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 234:79, 2001.
39. Van der Ent FWC, Kengen RAM, Van der Pol HAG, et al: Sentinel node biopsy in 70 unselected patients with breast cancer: Increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 25:24, 1999.
40. Hood AF, Kwan TH, Mihm MC, et al: Primer of Dermatopathology, 2d ed. Boston: Little, Brown, 1993.
41. Grant RN, Tabah EJ, Adair FF: The surgical significance of subareolar lymph plexus in cancer of the breast. Surgery 33:71, 1953.
42. Halsell JT, Smith JR, Bentlage CR, et al: Lymphatic drainage of the breast demonstrated by vital dye staining and radiography. Ann Surg 162:221, 1965.
43. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify the sentinel lymph node in breast cancer. Lancet 349:1668, 1997.
44. Borgstein PJ, Meijer S, Pijpers RJ, et al: Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg 232:81, 2000.
45. Sappey MPC: Injection preparation et conservation des vaisseaux lymphatiques. These pour le doctorat en medecine, no 241. Paris: Rignoux Imprimeur de la Faculte de Medecine, 1834.
46. Turner-Warwick RT: The lymphatics of the breast. Br J Surg 46:574, 1959.
47. Spratt JS: Anatomy of the breast. Major Problems in Clinical Surgery 5:1, 1979.
48. Bland KI, Copeland EM: The breast. In: Comprehensive Management of Benign and Malignant Diseases, 2d ed. Philadelphia: WB Saunders, 1998.